Masseter muscle defined sarcopenia and survival in head and neck cancer patients at a single cancer centre

Abstract

Introduction and aim: Sarcopenia is increasingly recognised as a poor prognostic factor in older patients undergoing cancer treatment. Recently, masseter muscle cross sectional area (MMCSA) has been shown to accurately identify sarcopenic patients. We aimed to apply this novel technique to a head and neck oncology patient cohort to identify any potential relationship with survival.